<?xml version="1.0" encoding="UTF-8"?>
<ref id="ref107">
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sun</surname>
    <given-names>W.</given-names>
   </name>
   <name>
    <surname>Kirkpatrick</surname>
    <given-names>E.</given-names>
   </name>
   <name>
    <surname>Ermler</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Nachbagauer</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Broecker</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Krammer</surname>
    <given-names>F.</given-names>
   </name>
   <etal/>
  </person-group>. (
  <year>2019</year>). 
  <article-title>Development of influenza B universal vaccine candidates using the “mosaic” Hemagglutinin approach</article-title>. 
  <source>J. Virol.</source>
  <volume>93</volume>, 
  <fpage>1</fpage>–
  <lpage>17</lpage>. 
  <pub-id pub-id-type="doi">10.1128/JVI.00333-19</pub-id>, PMID: 
  <?supplied-pmid 30944178?>
  <pub-id pub-id-type="pmid">30944178</pub-id>
 </mixed-citation>
</ref>
